Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $40.7150 (0.23%) ($39.9100 - $41.2300) on Wed. Dec. 2, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.1% (three month average) | RSI | 64 | Latest Price | $40.7150(0.23%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | HALO advances 1.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(51%) IWM(49%) IWC(46%) IWN(43%) | Factors Impacting HALO price | HALO will decline at least -1.55% in a week (0% probabilities). VIXM(-31%) VXX(-13%) UUP(-13%) TLT(-1%) TBT(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.55% (StdDev 3.1%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $40.37(0.85%) | 10 Day Moving Average | $39.98(1.84%) | 20 Day Moving Average | $38.79(4.96%) | To recent high | -1.1% | To recent low | 58.2% | Market Cap | $5.565b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |